Hester Biosciences Limited (BOM:524669)
India flag India · Delayed Price · Currency is INR
2,317.10
+11.60 (0.50%)
At close: Sep 9, 2026

Hester Biosciences Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
556.39274.88188.89266.27393.2
Depreciation & Amortization
186.78166.17170.64205.73165.27
Other Amortization
2.031.851.11.220.54
Loss (Gain) From Sale of Assets
2.044.86-0.28-0.16-0.69
Loss (Gain) From Sale of Investments
-17.57----
Loss (Gain) on Equity Investments
-93.09-41-46.09-44.09-4.23
Provision & Write-off of Bad Debts
67.3644.717.125.2824.57
Other Operating Activities
248.9294.19123.7110.09-103.74
Change in Accounts Receivable
-291.2916.153.95-249.65-87.79
Change in Inventory
-35.5252.0492.29-94.28-131.6
Change in Accounts Payable
-31.1936.51-37.27119.64-100.67
Change in Other Net Operating Assets
46.55-5.25-22.2315.91-67.74
Operating Cash Flow
641.41645.11481.83235.9687.12
Operating Cash Flow Growth
-0.57%33.89%104.20%170.84%-84.99%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-178.28-205.91-243.97-777.62-957.1
Sale of Property, Plant & Equipment
3.872.740.550.251.79
Divestitures
79.6----
Investment in Securities
-9.194.88-1.582.28-213.21
Other Investing Activities
20.318.2618.945.12.64
Investing Cash Flow
-28.69-190.03-226.06-769.99-1,166

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
---240.13315.66
Long-Term Debt Issued
--204.74320.441,033
Total Debt Issued
--204.74560.571,349
Short-Term Debt Repaid
-52.93-17.72-275.07--
Long-Term Debt Repaid
-308.34-316.5-232.66-172-181.18
Lease Payments
-2.74-3.06-3-0.63-0.74
Total Debt Repaid
-361.27-334.22-507.73-172-181.18
Net Debt Issued (Repaid)
-361.27-334.22-302.99388.571,168
Common Dividends Paid
-60.26-51.68-68.53-85.07-85.07
Other Financing Activities
-66.41-131.27110.59114.0832.48
Financing Cash Flow
-487.94-517.17-260.93417.581,115

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
-148.8-5.111.570.51-1.79
Miscellaneous Cash Flow Adjustments
-4.18----
Net Cash Flow
-28.2-67.2-3.59-115.9434.81

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
463.13439.2237.86-541.66-869.98
Free Cash Flow Growth
5.45%84.65%---
Free Cash Flow Margin
13.86%14.06%7.64%-19.47%-35.27%
Free Cash Flow Per Share
54.4451.6327.96-63.67-102.27
Levered Free Cash Flow
288.43464.9-23.69-507.55-764.94
Unlevered Free Cash Flow
334.78517.0333.31-475.37-748.84
Free Cash Flow After Leases
460.39436.14234.86-542.29-870.72

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
66.41131.27149.41125.9225.38
Cash Income Tax Paid
141.24114.71116.6681.07171.09
Change in Working Capital
-311.4599.4536.74-208.38-387.8